Companies

GW Pharmaceuticals Plc. Soared 1,030%, with More Gains to Come

GW Pharmaceuticals Plc. Soared 1,030%, with More Gains to Come

GW Pharmaceuticals Plc. Soared 1,030%, with More Gains to Come

GW Pharmaceuticals Plc. is a biopharmaceutical company that discovers, develops, and commercializes cannabinoid prescription medicines. Since May 10, 2013, the stock price has climbed 1,033%.

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors

The 1 Word in GW Pharmaceuticals’ Q3 Update That Disappointed Investors

When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.

4 Canadian Marijuana Stocks in Great Financial Health

4 Canadian Marijuana Stocks in Great Financial Health

Identifying companies in great financial health is important when investing in an industry like marijuana. That being said, the Canadian marijuana stocks on our list all have current ratios of at least 10x, and debt to equity ratios under 20%.

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

In mid-June home lawn and fertilizer care specialist The Scotts Miracle-Gro Company (NYSE:SMG) lowered its full-year fiscal 2017 outlook, citing a more than 10% drop in mass retail sales compared to the year-to-date checkpoint from the previous year. That was caused by challenging weather this spring in core markets across the United States.

Flickr / Jen Montgomery / (CC BY-NC-ND 2.0)

The Average Marijuana Stock Is Up 332% Over the Past Year

Over the trailing-12-month period through July 15, the average marijuana stock with a market cap in excess of $200 million — a dozen stocks in total, which excluded MedReleaf because it just went public a month ago — was up by 332%.

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there’s the third type: the biotechs. Zynerba Pharmaceuticals belongs to the last kind of marijuana stock.

Cara Therapeutics Stock Has Lost More Than Half Its Value in 2 Weeks

Cara Therapeutics Stock Has Lost More Than Half Its Value in 2 Weeks

On June 27, Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech company with a focus on treating chronic pain and pruritus, surged to an all-time intraday high of $28.50 a share. Cara was just $73 million away from joining the $1 billon market cap ranks.

Betting on Pot in the Stock Market - Canadian Cannabis

Betting on Pot in the Stock Market

Since Justin Trudeau’s election, the Canadian cannabis space has seen significant growth both in public and private sectors. The industry is gearing up for its entry into the legal recreational cannabis market set to open up by July 1, 2018.

Better Know a Marijuana Stock: MedReleaf Corp.

Better Know a Marijuana Stock: MedReleaf Corp.

MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. today is one of the pre-eminent marijuana producers listed on the TSX Venture Exchange with a market capitalization just shy of $750 million, making it the fourth-largest marijuana stock behind only GW Pharmaceuticals PLC- ADR, Canopy Growth Corp., and Aphria Inc.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.

The Very First Cannabis Stock ETF Is Now in Bear-Market Territory

The Very First Cannabis Stock ETF is Now in Bear-Market Territory

The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.

Say Hello to the Largest North American Marijuana Stock IPO

Say Hello to the Largest North American Marijuana Stock IPO

In April, investors were privy to the very first marijuana stock ETF, which debuted on the Toronto Stock Exchange with slightly more than a dozen holdings. This represented the very first time a basket fund was created for investors to easily diversify their pot-stock holdings. And last week, investors witnessed another marijuana first: the largest North American marijuana stock IPO of all-time.

Canadian Cannabis Investors Bogart Deals in America

Canadian Cannabis Investors Bogart Deals in America

There is so much Canadian cannabis investment money right now that it is cascading down into the United States and Canadian investors are easily outbidding domestic acquirers.

Green bubble? Cannabis investors on white-knuckle ride as share prices fall

Green Bubble? Cannabis Investors on White-Knuckle Ride as Share Prices Fall

Canadian marijuana stocks have been on a punishing slide for three straight months despite a temporary blip of investor fever in April that sent share prices soaring to record highs as Ottawa tabled legislation to legalize pot.

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?

High Times Acquisition: Company Valued at $70 Million

High Times Acquisition: Company Valued at $70 Million

On June 1, 2017, High Times announced that controlling interest in the company had been acquired by 20 investors, a group comprised of cannabis industry members, entrepreneurs and entertainment veterans. Oreva Capital, a Los Angeles-based investment firm, led the High Times acquisition, valuing the company at $70 million. The company will now operate as High Times Holding Company.


Page 1 of 712345...Last »
Top